Seeking victory
for patients
Your victory is our victory, too.
At Silverback, we’re developing a new kind of therapy – one that can better arm the patient’s immune system against devastating diseases.
Seeking victory
When the patient wins,
everyone wins
Using our ImmunoTAC platform, we believe it’s possible to develop systemically delivered, tissue-targeted therapeutics for the treatment of cancer, chronic viral infections and other serious diseases.
We’re tackling a classic problem with a new perspective.
We’ve designed our new generation of systemically delivered, tissue-targeted therapies to help modulate fundamental disease pathways once thought inaccessible.